Pro Share Advisors LLC Glycomimetics Inc Transaction History

Pro Share Advisors LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$2.69 - $4.24 $32,909 - $51,872	-12,234 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.07 - $5.0 $2,063 - $3,360	672 Added 5.81%	12,234 $38,000
Q2 2020 Aug 03, 2020	BUY	$2.06 - $3.76 $23,817 - $43,473	11,562 New	11,562 $43,000
Q1 2020 May 15, 2020	SELL	$1.83 - $5.41 $25,548 - $75,529	-13,961 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$4.03 - $6.5 $6,379 - $10,289	-1,583 Reduced 10.18%	13,961 $74,000
Q3 2019 Nov 12, 2019	SELL	$2.8 - $12.85 $1,875 - $8,609	-670 Reduced 4.13%	15,544 $67,000
Q2 2019 Aug 13, 2019	SELL	$10.6 - $13.12 $22,737 - $28,142	-2,145 Reduced 11.68%	16,214 $193,000
Q1 2019 May 15, 2019	BUY	$9.96 - $13.44 $1,484 - $2,002	149 Added 0.82%	18,359 $229,000
Q4 2018 Feb 14, 2019	SELL	$8.47 - $14.71 $29,780 - $51,720	-3,516 Reduced 16.18%	18,210 $172,000
Q3 2018 Nov 14, 2018	SELL	$13.7 - $17.12 $7,740 - $9,672	-565 Reduced 2.53%	21,726 $313,000
Q2 2018 Aug 13, 2018	BUY	$14.63 - $19.19 $93,836 - $123,084	6,414 Added 40.4%	22,291 $360,000
Q1 2018 May 14, 2018	SELL	$16.06 - $25.35 $42,093 - $66,442	-2,621 Reduced 14.17%	15,877 $258,000
Q4 2017 Feb 14, 2018	BUY	$10.51 - $17.22 $194,413 - $318,535	18,498	18,498 $311,000

17.8M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $16.3M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.